Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFeng, F.-
dc.contributor.authorHarper, R.-
dc.contributor.authorReynolds, P.-
dc.identifier.citationRespirology, 2016; 21(3):526-532-
dc.description.abstractBackground and objective: Idiopathic, familial and secondary pulmonary arterial hypertension (PAH) are associated with reduced bone morphogenetic protein receptor type 2 (BMPR2) expression, and in some contexts, TGF-β upregulation. Our aims were to assess BMPR2 gene therapy in a PAH mouse model and to assess the impact on TGF-β signalling. Methods: Using a targeted in vivo gene delivery approach, we assessed the impact of BMPR2 gene delivery in a transgenic mouse model in which PAH was first induced by doxycycline driven expression of a dominant negative BMPR2 mutant (R899X). We also assessed the impact of BMPR2 gene delivery on TGF-β-induced changes in cell signalling in human pulmonary vascular endothelial and smooth muscle cells. Results: In the mouse model, changes in TGF-β levels were not detected, but BMPR2 gene delivery reversed the increase in right ventricle systolic pressure (RVSP) and Fulton Index (FI), associated with a trend to increased pulmonary endothelial nitric oxide synthase (eNOS) gene expression. In vitro, BMPR2 gene transfer reduced TGF-β effects on Smad2, Smad1/5/8 and Erk1/2 phosphorylation in human pulmonary arterial smooth muscle cells (HPASMC). BMPR2 was also found to upregulate nitric oxide (NO) production in lung derived human microvascular endothelial cells (HMVEC-L). Conclusion: This study provides further evidence that BMPR2 modulation may have therapeutic potential.-
dc.description.statementofresponsibilityFeng Feng, Rebecca L Harper and Paul N Reynolds-
dc.rights© 2015 Asian Pacific Society of Respirology-
dc.subjectGenetics; molecular biology; nitric oxide; pulmonary circulation and pulmonary hypertension-
dc.titleBMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling-
dc.title.alternativeBMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-beta-mediated pulmonary cell signalling-
dc.typeJournal article-
dc.identifier.orcidHarper, R. [0000-0003-1465-7372]-
dc.identifier.orcidReynolds, P. [0000-0002-2273-1774]-
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.